Supplementary Data from Phase II Clinical Trial of Eribulin–Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)